Importantly, our approach resulted in the discovery of how APLP2 gene ablation in the SOD1-G37R mouse resulted in a significant increase in survivability in the female but not male mouse demonstrating a clear sex-based difference in MND. The gene discussed is SOD1; the disease is mild neurocognitive disorder.